OncoCyte Corp (OCX)

4.02
0.09 2.30
AMEX : Health Care
Prev Close 3.93
Open 3.97
Day Low/High 3.87 / 4.03
52 Wk Low/High 2.45 / 10.24
Volume 2.02K
Avg Volume 24.60K
Exchange AMEX
Shares Outstanding 25.43M
Market Cap 102.23M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

OncoCyte Reports Second Quarter 2016 Financial Results

OncoCyte Reports Second Quarter 2016 Financial Results

Conference Call to Discuss the Results at 5:00 p.m. ET

OncoCyte Commences Analytical Verification Study For Lung Cancer Diagnostic Test

OncoCyte Commences Analytical Verification Study For Lung Cancer Diagnostic Test

Expects to Complete the Studies Later this Year and Continues to Project Commercial Launch in the First Half of 2017

BioTime, Inc. Reports Second Quarter Results And Recent Corporate Accomplishments

BioTime, Inc. Reports Second Quarter Results And Recent Corporate Accomplishments

BioTime, Inc. (NYSE MKT:BTX), a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today reported financial results for the second quarter ended June 30, 2016 and provided a...

WireCo Announces Investment From Onex

WireCo Announces Investment From Onex

OncoCyte To Release Bladder Cancer Data At The 2016 American Society Of Clinical Oncology Annual Meeting

OncoCyte To Release Bladder Cancer Data At The 2016 American Society Of Clinical Oncology Annual Meeting

Positive New Data to be Featured in a Poster Discussion

OncoCyte Reports First Quarter 2016 Financial Results

OncoCyte Reports First Quarter 2016 Financial Results

Conference Call to Discuss the Results at 5 p.m. ET

10 Worst-Performing Small-Cap Stocks in 2016

10 Worst-Performing Small-Cap Stocks in 2016

With small-cap stocks taking a beating this month, some of the worst performers include companies in the shipping, biotech and, of course, energy sectors.

Allison Transmission’s CEO Says Some Weak Markets Have Bottomed

Allison Transmission’s CEO Says Some Weak Markets Have Bottomed

The CEO of Allison Transmission (ALSN) sees some slowing in its North America business, but believes weakness is some of its key markets may have bottomed.

The Deal: Nielsen Pockets $950 Million to Finance Arbitron Acquisition

The Deal: Nielsen Pockets $950 Million to Finance Arbitron Acquisition

Nielsen said Monday it plans to sell its expositions business to Onex Corp. for $950 million, boosting cash for Arbitron acquisition.

Citi Considers Partial Sale of OneMain: Report

Citigroup may retain a minority stake in its consumer finance business rather than sell the entire franchise as initially planned, according to a news report.

From Our Partners